SZUKF (Suzuken Co) Cyclically Adjusted Revenue per Share: $146.36 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZUKF Suzuken Co Ltd SZUKF
79 GF Score
Price $30.30
GF Value $35.94
! 1 Warning Sign
View Full Analysis

What is Suzuken Co Cyclically Adjusted Revenue per Share?

Suzuken Co SZUKF +4.88% 79 Cyclically Adjusted Revenue per Share is $146.36 as of Mar. 2026. GuruFocus rates SZUKF with a GF Score™ of 79/100 and a GF Value™ of $35.94. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Suzuken Co's adjusted revenue per share for the three months ended in Mar. 2026 was $54.171. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $146.36 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Suzuken Co's average Cyclically Adjusted Revenue Growth Rate was 4.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 5.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Suzuken Co was 6.20% per year. The lowest was 2.80% per year. And the median was 4.50% per year.

As of today (2026-08-17), Suzuken Co's current stock price is $30.30. Suzuken Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $146.36. Suzuken Co's Cyclically Adjusted PS Ratio of today is 0.21.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Suzuken Co was 0.33. The lowest was 0.13. And the median was 0.19.


Suzuken Co  (OTCPK:SZUKF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Suzuken Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=30.30/146.36
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Suzuken Co was 0.33. The lowest was 0.13. And the median was 0.19.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Suzuken Co Cyclically Adjusted Revenue per Share Related Terms


Suzuken Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Suzuken Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suzuken Co Cyclically Adjusted Revenue per Share Chart

Suzuken Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 166.13 173.61 133.19 167.62 146.36

Suzuken Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 161.26 146.22 141.09 146.36 0.00

SZUKF vs MCK, COR, CAH: Cyclically Adjusted Revenue per Share Comparison

For the Medical Distribution subindustry, Suzuken Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzuken Co Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Suzuken Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Suzuken Co's Cyclically Adjusted PS Ratio falls into.


SZUKF
79GF Score
Suzuken Co Ltd SZUKF
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Suzuken Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Suzuken Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=54.171/112.7000*112.7000
=54.171

Current CPI (Mar. 2026) = 112.7000.

Suzuken Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 51.036 98.100 58.632
201609 51.760 98.000 59.524
201612 48.575 98.400 55.634
201703 47.025 98.100 54.024
201706 49.709 98.500 56.875
201709 49.504 98.800 56.469
201712 53.325 99.400 60.460
201803 50.460 99.200 57.327
201806 49.861 99.200 56.647
201809 48.241 99.900 54.422
201812 54.499 99.700 61.605
201903 52.012 99.700 58.794
201906 55.418 99.800 62.581
201909 57.826 100.100 65.105
201912 57.561 100.500 64.549
202003 54.355 100.300 61.075
202006 53.873 99.900 60.776
202009 55.808 99.900 62.959
202012 61.000 99.300 69.232
202103 53.758 99.900 60.646
202106 55.300 99.500 62.636
202109 57.693 100.100 64.955
202112 58.753 100.100 66.148
202203 52.758 101.100 58.811
202206 47.005 101.800 52.038
202209 46.379 103.100 50.698
202212 53.742 104.100 58.182
202303 50.323 104.400 54.324
202306 49.052 105.200 52.549
202309 50.748 106.200 53.854
202312 53.127 106.800 56.062
202403 49.085 107.200 51.603
202406 47.502 108.200 49.478
202409 55.415 108.900 57.349
202412 54.165 110.700 55.144
202503 49.621 111.100 50.336
202506 57.103 111.700 57.614
202509 59.511 112.000 59.883
202512 60.583 113.000 60.422
202603 54.171 112.700 54.171

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $146.36 mean?
Suzuken Co (SZUKF) has a Cyclically Adjusted Revenue per Share of $146.36 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Suzuken Co and its competitors.
Is Suzuken Co's Cyclically Adjusted Revenue per Share too high?
Suzuken Co's current Cyclically Adjusted Revenue per Share is $146.36. Overall, Suzuken Co has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Suzuken Co's Cyclically Adjusted Revenue per Share compare to MCK and COR?
Suzuken Co's Cyclically Adjusted Revenue per Share of $146.36 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Distribution company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Suzuken Co and its competitors. Suzuken Co's current Cyclically Adjusted Revenue per Share is $146.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzuken Co stock overvalued right now?
Suzuken Co (SZUKF) has a current Cyclically Adjusted Revenue per Share of $146.36. The stock's GF Value™ is $35.94, compared to a current price of $30.30 — trading 15.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $146.36. Suzuken Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Suzuken Co (SZUKF), the current Cyclically Adjusted Revenue per Share is $146.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Suzuken Co (SZUKF) Overvalued in 2026?

Based on GuruFocus' analysis, Suzuken Co stock appears to be undervalued. The current stock price of $30.30 is trading 15.7% below its estimated GF Value™ of $35.94.

Key valuation signals for SZUKF:

  • Cyclically Adjusted Revenue per Share: $146.36
  • GF Value™: $35.94 vs. price of $30.30 (15.7% below fair value)
  • GF Score™: 79/100 with 1 warning sign

No single metric tells the full story. See the SZUKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Suzuken Co Business Description

Other Exchanges 9987:JapanZU1:Germany
Address 8 Higashikatabatacho, Higashi Ward, Aichi Prefecture, Nagoya, JPN, 461-8701
Suzuken Co Ltd is engaged in the manufacture and sale of pharmaceuticals and medical devices, and in providing insurance, pharmacy, and nursing care services. The company operates through segments, including Pharmaceutical Wholesale business, Healthcare product development business, Specialty Pharmaceuticals Distribution business, Regional medical nursing care support business, and Medical-related Services business. It generates the majority of its revenue from the Pharmaceutical Wholesale Business segment, which sells prescription pharmaceuticals, diagnostic reagents, medical equipment, and medical supplies.
79GF Score

Get the complete analysis for SZUKF

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$30.30
Price
$35.94
GF Value